Celltrion Celebrates Brazilian Tender Win For Infliximab

Remsima Win Follows Truxima (Rituximab) And Herzuma (Trastuzumab) Biosimilars

 
• By David Wallace
  
Brazil flag sky sun
Remsima has become the third Celltrion biosimilar to win a Brazilian tender • Source: Wavebreak Media ltd / Alamy Stock Photo
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products